VAN TUYL CHRISTOPHER (Chief Legal Officer) sold 0.7% of their position (1.21K shares) of IMMUNOVANT, INC. on the open market
Open‑market sale worth $47.7K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 7/10/2026ACC: 0001764013-26-000082
Officer· Chief Legal Officer
Since Dec 2024
-1.21K
Net shares
Net seller
$47.7K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
1.21K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−1.14K
Price / share
$39.53
Trade value
$45.18K
% of position
0.6%
7/8/2026
180.60K→179.45K
Common Stock
Direct
Shares
−63.00
Price / share
$39.99
Trade value
$2.52K
% of position
0.0%
7/8/2026
179.45K→179.39K
Total
Net shares
−1.21K
Net value
-$47.70K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/8/2026 | S · Sale | −1.14K | $39.53 | $45.18K | 0.6% | 180.60K | 179.45K |
| Common Stock Direct | 7/8/2026 | S · Sale | −63.00 | $39.99 | $2.52K | 0.0% | 179.45K | 179.39K |
| Total | −1.21K | -$47.70K | ||||||
Derivative Transactions0
No derivative transactions reported